Previous Article | Next Article 
Molecular and Cellular Biology, December 1999, p. 8442-8450, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Distinct Cellular Factors Regulate the
c-myb Promoter through Its E2F Element
Miguel R.
Campanero,
Monica
Armstrong, and
Erik
Flemington*
Harvard University and Dana-Farber Cancer
Institute, Boston, Massachusetts 02115
Received 11 February 1999/Returned for modification 31 March
1999/Accepted 30 August 1999
Most E2F-driven promoters are transiently activated around the
G1/S transition. Although the promoter for the
c-myb proto-oncogene harbors an E2F element, it is induced
early in G1 following entry into the cell cycle.
Furthermore, this promoter remains active throughout subsequent cell
cycles. Since E2F sites function as repressor elements during
G1 (due to the association of pRb with E2F factors), we
investigated whether the E2F element in the c-myb promoter
is regulated differently than E2F elements in promoters that are
repressed during G1. By gel shift analysis, the E2F element from the c-myb promoter was found to form a unique complex,
referred to as E2Fmyb-sp, which was not observed with E2F elements from several other promoters. Antibodies to DP-1, E2F1 to -5, p107, or pRb
failed to either supershift or block E2Fmyb-sp complex formation.
Methylation interference experiments indicate that the DNA contact
residues for the E2Fmyb-sp complex are distinct from but overlapping
with residues required for the binding of E2F proteins. In addition to
the identification of E2Fmyb-sp, we have found that SP-1 binds to the
c-myb E2F element. Functional studies revealed that
E2Fmyb-sp and/or SP-1 are required to achieve full activation of the
c-myb promoter in different cell types and to maintain
elevated expression of the c-myb promoter during G1 in NIH 3T3 cells. These studies demonstrate that E2F
elements can be regulated differently through the binding of unique
sets of proteins.
*
Corresponding author. Mailing address: Harvard
University and Dana-Farber Cancer Institute, 44 Binney St., Boston, MA
02115. Phone: (617) 632-3852. Fax: (617) 632-2662. E-mail:
erik_flemington{at}dfci.harvard.edu.
Molecular and Cellular Biology, December 1999, p. 8442-8450, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Molina-Privado, I., Rodriguez-Martinez, M., Rebollo, P., Martin-Perez, D., Artiga, M.-J., Menarguez, J., Flemington, E. K., Piris, M. A., Campanero, M. R.
(2009). E2F1 Expression Is Deregulated and Plays an Oncogenic Role in Sporadic Burkitt's Lymphoma. Cancer Res.
69: 4052-4058
[Abstract]
[Full Text]
-
Alvaro-Blanco, J., Martinez-Gac, L., Calonge, E., Rodriguez-Martinez, M., Molina-Privado, I., Redondo, J. M., Alcami, J., Flemington, E. K., Campanero, M. R.
(2009). A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence. Carcinogenesis
30: 440-448
[Abstract]
[Full Text]
-
Montanuy, I., Torremocha, R., Hernandez-Munain, C., Sune, C.
(2008). Promoter Influences Transcription Elongation: TATA-BOX ELEMENT MEDIATES THE ASSEMBLY OF PROCESSIVE TRANSCRIPTION COMPLEXES RESPONSIVE TO CYCLIN-DEPENDENT KINASE 9. J. Biol. Chem.
283: 7368-7378
[Abstract]
[Full Text]
-
Davis, J. N., McCabe, M. T., Hayward, S. W., Park, J. M., Day, M. L.
(2005). Disruption of Rb/E2F Pathway Results in Increased Cyclooxygenase-2 Expression and Activity in Prostate Epithelial Cells. Cancer Res.
65: 3633-3642
[Abstract]
[Full Text]
-
Davidson, C. J., Tirouvanziam, R., Herzenberg, L. A., Lipsick, J. S.
(2005). Functional Evolution of the Vertebrate Myb Gene Family: B-Myb, but Neither A-Myb nor c-Myb, Complements Drosophila Myb in Hemocytes. Genetics
169: 215-229
[Abstract]
[Full Text]
-
Lin, Z., Yin, Q., Flemington, E.
(2004). Identification of a Negative Regulatory Element in the Epstein-Barr Virus Zta Transactivation Domain That Is Regulated by the Cell Cycle Control Factors c-Myc and E2F1. J. Virol.
78: 11962-11971
[Abstract]
[Full Text]
-
Martinez-Gac, L., Marques, M., Garcia, Z., Campanero, M. R., Carrera, A. C.
(2004). Control of Cyclin G2 mRNA Expression by Forkhead Transcription Factors: Novel Mechanism for Cell Cycle Control by Phosphoinositide 3-Kinase and Forkhead. Mol. Cell. Biol.
24: 2181-2189
[Abstract]
[Full Text]
-
Konishi, Y., Bonni, A.
(2003). The E2F-Cdc2 Cell-Cycle Pathway Specifically Mediates Activity Deprivation-Induced Apoptosis of Postmitotic Neurons. J. Neurosci.
23: 1649-1658
[Abstract]
[Full Text]
-
Lauder, A., Castellanos, A., Weston, K.
(2001). c-myb Transcription Is Activated by Protein Kinase B (PKB) following Interleukin 2 Stimulation of T Cells and Is Required for PKB-Mediated Protection from Apoptosis. Mol. Cell. Biol.
21: 5797-5805
[Abstract]
[Full Text]
-
Thykjaer, T., Workman, C., Kruhøffer, M., Demtröder, K., Wolf, H., Andersen, L. D., Frederiksen, C. M., Knudsen, S., Ørntoft, T. F.
(2001). Identification of Gene Expression Patterns in Superficial and Invasive Human Bladder Cancer. Cancer Res.
61: 2492-2499
[Abstract]
[Full Text]
-
Campanero, M. R., Armstrong, M. I., Flemington, E. K.
(2000). CpG methylation as a mechanism for the regulation of E2F activity. Proc. Natl. Acad. Sci. USA
97: 6481-6486
[Abstract]
[Full Text]